These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 34474875)

  • 1. Bioinspired particle engineering for non-invasive inhaled drug delivery to the lungs.
    Shukla SK; Sarode A; Kanabar DD; Muth A; Kunda NK; Mitragotri S; Gupta V
    Mater Sci Eng C Mater Biol Appl; 2021 Sep; 128():112324. PubMed ID: 34474875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Particle shape engineering for improving safety and efficacy of doxorubicin - A case study of rod-shaped carriers in resistant small cell lung cancer.
    Shukla SK; Sarode A; Wang X; Mitragotri S; Gupta V
    Biomater Adv; 2022 Jun; 137():212850. PubMed ID: 35929278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design and evaluation of novel inhalable sildenafil citrate spray-dried microparticles for pulmonary arterial hypertension.
    Shahin HI; Vinjamuri BP; Mahmoud AA; Shamma RN; Mansour SM; Ammar HO; Ghorab MM; Chougule MB; Chablani L
    J Control Release; 2019 May; 302():126-139. PubMed ID: 30940497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transport of ellipsoid fibers in oscillatory shear flows: Implications for aerosol deposition in deep airways.
    Shachar-Berman L; Ostrovski Y; De Rosis A; Kassinos S; Sznitman J
    Eur J Pharm Sci; 2018 Feb; 113():145-151. PubMed ID: 28942008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In Vitro Pulmonary Cell Culture in Pharmaceutical Inhalation Aerosol Delivery: 2-D, 3-D, and In Situ Bioimpactor Models.
    Acosta MF; Muralidharan P; Meenach SA; Hayes D; M-Black S; Mansour HM
    Curr Pharm Des; 2016; 22(17):2522-31. PubMed ID: 26831643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chitosan/bovine serum albumin layer-by-layer assembled particles for non-invasive inhaled drug delivery to the lungs.
    Chauhan G; Wang X; Quadros M; Vats M; Gupta V
    Int J Biol Macromol; 2024 Jun; 271(Pt 2):132526. PubMed ID: 38782317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dynamic mucus penetrating microspheres for efficient pulmonary delivery and enhanced efficacy of host defence peptide (HDP) in experimental tuberculosis.
    Sharma A; Vaghasiya K; Gupta P; Singh AK; Gupta UD; Verma RK
    J Control Release; 2020 Aug; 324():17-33. PubMed ID: 32418903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Swellable microparticles as carriers for sustained pulmonary drug delivery.
    El-Sherbiny IM; McGill S; Smyth HD
    J Pharm Sci; 2010 May; 99(5):2343-56. PubMed ID: 19967777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rifabutin loaded inhalable β-glucan microparticle based drug delivery system for pulmonary TB.
    Ahmad F; Ahmad S; Upadhyay TK; Singh S; Khubaib M; Singh J; Saeed M; Ahmad I; Al-Keridis LA; Sharma R
    Sci Rep; 2024 Jul; 14(1):16437. PubMed ID: 39013991
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deposition of non-spherical particles in bifurcating airways.
    Bunchatheeravate P; Curtis JS
    Pharm Dev Technol; 2014 Dec; 19(8):942-51. PubMed ID: 24320756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation and characterization of novel magnetic nano-in-microparticles for site-specific pulmonary drug delivery.
    McBride AA; Price DN; Lamoureux LR; Elmaoued AA; Vargas JM; Adolphi NL; Muttil P
    Mol Pharm; 2013 Oct; 10(10):3574-81. PubMed ID: 23964796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and Evaluation of Chitosan Microparticles Based Dry Powder Inhalation Formulations of Rifampicin and Rifabutin.
    Pai RV; Jain RR; Bannalikar AS; Menon MD
    J Aerosol Med Pulm Drug Deliv; 2016 Apr; 29(2):179-95. PubMed ID: 26406162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Porous particles and novel carrier particles with enhanced penetration for efficient pulmonary delivery of antitubercular drugs.
    Tse JY; Koike A; Kadota K; Uchiyama H; Fujimori K; Tozuka Y
    Eur J Pharm Biopharm; 2021 Oct; 167():116-126. PubMed ID: 34363979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Superparamagnetic iron oxide nanoparticles (SPIONs)-loaded Trojan microparticles for targeted aerosol delivery to the lung.
    Tewes F; Ehrhardt C; Healy AM
    Eur J Pharm Biopharm; 2014 Jan; 86(1):98-104. PubMed ID: 24055690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Study on the Pulmonary Delivery System of Apigenin-Loaded Albumin Nanocarriers with Antioxidant Activity.
    Pápay ZE; Kósa A; Böddi B; Merchant Z; Saleem IY; Zariwala MG; Klebovich I; Somavarapu S; Antal I
    J Aerosol Med Pulm Drug Deliv; 2017 Aug; 30(4):274-288. PubMed ID: 28282259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhalable nanocomposite microparticles: preparation, characterization and factors affecting formulation.
    Elsayed I; AbouGhaly MH
    Expert Opin Drug Deliv; 2016; 13(2):207-22. PubMed ID: 26512950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of drug particle shape on permeability and cellular uptake in the lung.
    Zellnitz S; Zellnitz L; Müller MT; Meindl C; Schröttner H; Fröhlich E
    Eur J Pharm Sci; 2019 Nov; 139():105065. PubMed ID: 31493448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Substance deposition assessment in obstructed pulmonary system through numerical characterization of airflow and inhaled particles attributes.
    Lalas A; Nousias S; Kikidis D; Lalos A; Arvanitis G; Sougles C; Moustakas K; Votis K; Verbanck S; Usmani O; Tzovaras D
    BMC Med Inform Decis Mak; 2017 Dec; 17(Suppl 3):173. PubMed ID: 29297393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Formulation of insulin-loaded N-trimethyl chitosan microparticles with improved efficacy for inhalation by supercritical fluid assisted atomization.
    Shen YB; Du Z; Tang C; Guan YX; Yao SJ
    Int J Pharm; 2016 May; 505(1-2):223-33. PubMed ID: 27034000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of Dry Powder Inhaler Carrier Targeted Design: A Comparative Case Study of Diverse Anomeric Compositions and Physical Properties of Lactose.
    Pinto JT; Zellnitz S; Guidi T; Roblegg E; Paudel A
    Mol Pharm; 2018 Jul; 15(7):2827-2839. PubMed ID: 29856921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.